The nuclear export signal-dependent localization of oligonucleopeptides enhances the inhibition of the protein expression from a gene transcribed in cytosol

Upon endocytosis, most oligodeoxynucleotides (ODNs) accumulate in vesicular compartments; a tiny number of them cross the vesicle membrane, reach the cytosol and by passive diffusion enter the nucleus where they are entrapped. So far, the compartment in which an antisense ODN interacts with its mRNA target has not been precisely characterized. In an attempt to answer this question, ODN-peptides were designed with the aim of maintaining them in the cytosol. This has been achieved by a short peptide sequence called the nuclear export signal (NES). Upon microinjection, ODN-NES peptide conjugates were efficiently and rapidly exported from the nucleus to the cytosol whereas ODN-peptides containing an inactive NES were found to be located in the nucleus. The inhibitory activity of antisense ODN was tested in a system allowing the specific transcription of a luciferase reporter gene in the cytosol. Antisense propynylated ODN-NES peptide conjugates, directed against the luciferase gene, efficiently inhibited (75%) the cytosolic expression of luciferase whereas at the same concentration the peptide-free propynylated ODN or the propynylated ODN-peptides containing an inactive NES were nearly inactive.

[1]  L. Gerace,et al.  Nuclear export signals and the fast track to the cytoplasm , 1995, Cell.

[2]  W. Flanagan,et al.  Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potency. , 1996, Nucleic acids research.

[3]  M. Monsigny,et al.  Synthesis and antiviral activity of peptide-oligonucleotide conjugates prepared by using N alpha-(bromoacetyl)peptides. , 1995, Bioconjugate chemistry.

[4]  Y. Wang,et al.  Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. , 1997, Chemistry & biology.

[5]  M. Stephenson,et al.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Bennett,et al.  Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. , 1992, Molecular pharmacology.

[7]  M. Strauss,et al.  High level gene expression in mammalian cells by a nuclear T7-phase RNA polymerase. , 1989, Nucleic acids research.

[8]  C. F. Bennett,et al.  Progress in antisense oligonucleotide therapeutics. , 1996, Annual review of pharmacology and toxicology.

[9]  F. Robey,et al.  Automated synthesis of N-bromoacetyl-modified peptides for the preparation of synthetic peptide polymers, peptide-protein conjugates, and cyclic peptides. , 1989, Analytical biochemistry.

[10]  E. Nishida,et al.  Nuclear export of actin: a novel mechanism regulating the subcellular localization of a major cytoskeletal protein , 1998, The EMBO journal.

[11]  R. Juliano,et al.  Cellular uptake and intracellular fate of antisense oligonucleotides. , 1992, Trends in cell biology.

[12]  D. Spiller,et al.  Nuclear delivery of antisense oligodeoxynucleotides through reversible permeabilization of human leukemia cells with streptolysin O. , 1995, Antisense research and development.

[13]  S. Wu‐Pong,et al.  Oligonucleotide biological activity: relationship to the cell cycle and nuclear transport. , 1997, Biology of the cell.

[14]  N M Dean,et al.  Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus. , 1998, Nucleic acids research.

[15]  E J Holborow,et al.  Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. , 1982, Journal of immunological methods.

[16]  L. Neckers,et al.  Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy. , 1993, Nucleic acids research.

[17]  B. Moss,et al.  Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5' untranslated leader. , 1989, Journal of molecular biology.

[18]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[19]  E. Wickstrom,et al.  Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes). , 1991, Nucleic acids research.

[20]  D. Spiller,et al.  Improving the intracellular delivery and molecular efficacy of antisense oligonucleotides in chronic myeloid leukemia cells: a comparison of streptolysin-O permeabilization, electroporation, and lipophilic conjugation. , 1998 .

[21]  E. Nishida,et al.  Nuclear export of cyclin B1 and its possible role in the DNA damage‐induced G2 checkpoint , 1998, The EMBO journal.

[22]  Utz Fischer,et al.  The HIV-1 Rev Activation Domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs , 1995, Cell.

[23]  C. Dargemont,et al.  Evidence for a role of CRM1 in signal-mediated nuclear protein export. , 1997, Science.

[24]  M Lemaitre,et al.  Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  V. Vlassov,et al.  Transport of oligonucleotides across natural and model membranes. , 1994, Biochimica et biophysica acta.

[26]  B. Froehler,et al.  Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. , 1993, Science.

[27]  Roger Y Tsien,et al.  Identification of a signal for rapid export of proteins from the nucleus , 1995, Cell.

[28]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Stein.  Phosphorothioate antisense oligodeoxynucleotides: questions of specificity. , 1996, Trends in biotechnology.

[30]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[31]  B. Lebleu,et al.  Intracellular distribution of microinjected antisense oligonucleotides. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  F. Szoka,et al.  Rapid nuclear accumulation of injected oligodeoxyribonucleotides. , 1990, The New biologist.

[33]  S. Crooke.  Therapeutic applications of oligonucleotides. , 1992, Bio/technology.

[34]  S. Kanaya,et al.  Functions and structures of ribonuclease H enzymes. , 1995, Sub-cellular biochemistry.

[35]  J. Toulmé,et al.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids. , 1990, Biochimica et biophysica acta.

[36]  G. Cantoni,et al.  Studies on a calf thymus ribonuclease specific for ribonucleic acid-deoxyribonucleic acid hybrids. , 1973, Biochemistry.

[37]  K. Wood,et al.  Firefly luciferase gene: structure and expression in mammalian cells , 1987, Molecular and cellular biology.

[38]  G. Dreyfuss,et al.  Nuclear export of proteins and RNAs. , 1997, Current opinion in cell biology.

[39]  Erich A. Nigg,et al.  Nucleocytoplasmic transport: signals, mechanisms and regulation , 1997, Nature.

[40]  Minoru Yoshida,et al.  CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals , 1997, Cell.